Samenvatting
Should professionals systematically screen whole-genome sequencing (WGS) data to check for life-threatening mutations? Alternatively, should genome analysis focus on the primary reason for testing – that is, aiming to achieve precision medicine? We present an ethical review of the arguments and compare the act of searching for mutations with disclosing mutations that are discovered incidentally.
| Originele taal-2 | Engels |
|---|---|
| Pagina's (van-tot) | 3-6 |
| Aantal pagina's | 4 |
| Tijdschrift | Trends in Molecular Medicine |
| Volume | 24 |
| Nummer van het tijdschrift | 1 |
| DOI's | |
| Status | Gepubliceerd - jan. 2018 |
| Extern gepubliceerd | Ja |